Related content

Overexpression of eNOS prevents the development of renovascular hypertension in mice

By Gava Agata L.   Peotta Veronica A.   Cabral Antonio M.   Vasquez Elisardo C.   Meyrelles Silvana S.  

Canadian Journal of Physiology and Pharmacology, Vol. 86, Iss. 7, 2008-07 ,pp. : 458-464

NRC Research Press

Access to resources Recommend Favorite

Reduction of eNOS in Vascular Smooth Muscle by Salt Independently of Hypertension

By  

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents), Vol. 15, Iss. 2, 2016-12 ,pp. : 135-144

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacological Prevention of eNOS Uncoupling

By  

Current Pharmaceutical Design, Vol. 20, Iss. 22, 2014-05 ,pp. : 3595-3606

Bentham Science Publishers

Access to resources Recommend Favorite

The HMG-CoA reductase inhibitor, pravastatin, prevents the development of monocrotaline-induced pulmonary hypertension in the rat through reduction of endothelial cell apoptosis and overexpression of eNOS

By Guerard Pascal   Rakotoniaina Zo   Goirand Françoise   Rochette Luc   Dumas Monique   Lirussi Frederic   Bardou Marc  

Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 373, Iss. 6, 2006-09 ,pp. : 401-414

Springer Publishing Company

Access to resources Recommend Favorite

Tetrahydrobiopterin Regulation of eNOS Redox Function

By  

Current Pharmaceutical Design, Vol. 20, Iss. 22, 2014-05 ,pp. : 3554-3562

Bentham Science Publishers

Access to resources Recommend Favorite